Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-25T19:05:13.299Z Has data issue: false hasContentIssue false
  • English
  • Français

Generalizing Costs from Trials: Analyzing Center Selection Bias in a Breast Screening Trial

Published online by Cambridge University Press:  10 March 2009

Katharine Johnston ,
Karen Gerard  and
Jackie Brown
Katharine Johnston
Affiliation:
Brunei University
Karen Gerard
Affiliation:
University of Newcastle upon Tyne
Jackie Brown
Affiliation:
Brunei University
Get access Rights & Permissions [Opens in a new window]

Abstract

With a growing number of economic evaluations being conducted alongside trials, there is a need to address, and if necessary, investigate the generalizability of results derived from trials. This paper explores the generalizability of costs from a trial investigating the frequency of breast cancer screening in the United Kingdom.

Type
General Essays
Information
International Journal of Technology Assessment in Health Care , Volume 14 , Issue 3 , Summer 1998 , pp. 494 - 504
Copyright
Copyright © Cambridge University Press 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Balthussen, R., Ament, A., & Leidl, R.Making cost assessments based on RCTs more useful to decision makers. Health Policy, 1996, 37, 163–83.Google Scholar
2.Briggs, A., Sculpher, M., & Buxton, M.Uncertainty in the economic evaluation of healthcare technologies: The role of sensitivity analysis. Health Economics, 1992, 3, 95–104.Google Scholar
3.Drummond, M. F., Bloom, B. S., Carrin, G., et al. Issues in the cross national assessment of health technology. International Journal of Technology Assessment in Health Care, 1992, 8, 671–82.Google Scholar
4.Drummond, M. F., & Davies, L.Economic analysis alongside clinical trials: Revisiting the methodological issues. International Journal of Technology Assessment in Health Care, 1991, 7, 561–73.Google Scholar
5.Gerard, K., Brown, J., Johnston, K., & Morton, A.The UK Breast Screening Programme: Local service organisation and delivery. Health Economics Research Group Discussion Paper No. 15. Uxbridge: Brunei University, 1996.Google Scholar
6.Jacobs, P., & Baladi, J. F.Biases in cost measurement for economic evaluation studies in health care. Health Economics, 1996, 5, 525–29.Google Scholar
7.Jefferson, T., Mugford, M., Gray, A., & Demicheli, V.An exercise on the feasibility of carrying out secondary economic analyses. Health Economics, 1996, 5, 155–65.Google Scholar
8.Johnston, K., Gerard, K., Morton, A., & Brown, J.NHS costs for the breast screening frequency and age trials. Health Economics Research Group Discussion Paper No 16, Uxbridge: Brunei University, 1996.Google Scholar
9.Leidl, R. M.Some factors to consider when using the results of economic evaluation studies at the population level. International Journal of Technology Assessment in Health Care, 1994, 10, 467–78.CrossRefGoogle ScholarPubMed